Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9438489rdf:typepubmed:Citationlld:pubmed
pubmed-article:9438489lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C0021758lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C0214743lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C1332717lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C1706438lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C0020846lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C0085358lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C1413244lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C2698600lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C0205345lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:9438489lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:9438489pubmed:issue6 Pt 1lld:pubmed
pubmed-article:9438489pubmed:dateCreated1998-2-2lld:pubmed
pubmed-article:9438489pubmed:abstractTextThe relative contribution of IL-4 and IL-13 to the regulation of IgE synthesis has remained relatively poorly characterized, partially because of lack of suitable animal models. We have studied the roles of IL-4 and IL-13 in human IgE synthesis induced by supernatants derived from activated CD4+ or CD8+ T cell clones. Neutralizing anti-IL-4 and anti-IL-13 monoclonal antibodies (mAbs) inhibited IgE synthesis induced by anti-CD40 mAbs and supernatants from CD4+ T cells by an average 61% and 42%, respectively (n = 25). Recombinant IL-13 had additive effects on IL-4-induced IgE synthesis, but only when IL-4 was present at low concentrations. Accordingly, IL-4 was the dominant IgE synthesis-inducing cytokine derived from highly polarized T helper (TH)2 cells. However, anti-IL-13 mAbs also significantly inhibited IgE synthesis induced by two of three supernatants derived from allergen-specific T(H2)-like cell lines generated from the skin of patients with atopic dermatitis. Furthermore, anti-IL-13 mAbs almost completely inhibited IgE synthesis induced by supernatants from T(H1) cells or CD8+ T cell clones. Taken together, these data indicate that IL-13, in addition to IL-4, contributes to IgE synthesis induced by all T helper cell subsets, including allergen-specific T(H2) cells. Moreover, IL-13 appears to be the major IgE synthesis-inducing cytokine derived from T(H1) cells or CD8+ T cells.lld:pubmed
pubmed-article:9438489pubmed:languageenglld:pubmed
pubmed-article:9438489pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438489pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9438489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438489pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438489pubmed:statusMEDLINElld:pubmed
pubmed-article:9438489pubmed:monthDeclld:pubmed
pubmed-article:9438489pubmed:issn0091-6749lld:pubmed
pubmed-article:9438489pubmed:authorpubmed-author:de VriesJ EJElld:pubmed
pubmed-article:9438489pubmed:authorpubmed-author:PunnonenJJlld:pubmed
pubmed-article:9438489pubmed:authorpubmed-author:YsselHHlld:pubmed
pubmed-article:9438489pubmed:issnTypePrintlld:pubmed
pubmed-article:9438489pubmed:volume100lld:pubmed
pubmed-article:9438489pubmed:ownerNLMlld:pubmed
pubmed-article:9438489pubmed:authorsCompleteYlld:pubmed
pubmed-article:9438489pubmed:pagination792-801lld:pubmed
pubmed-article:9438489pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:meshHeadingpubmed-meshheading:9438489-...lld:pubmed
pubmed-article:9438489pubmed:year1997lld:pubmed
pubmed-article:9438489pubmed:articleTitleThe relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells.lld:pubmed
pubmed-article:9438489pubmed:affiliationHuman Immunology Department, DNAX Research Institute of Molecular and Cellular Biology, Inc., Palo Alto, CA 94304-1104, USA.lld:pubmed
pubmed-article:9438489pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9438489pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9438489lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9438489lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9438489lld:pubmed